Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma

Surgery Today

Volumn 34, Issue 10, 2004, Pages 842-848

  Ohba, Kazuki ^a   Kubo, Shoji ^a   Tamori, Akihiro ^a   Hirohashi, Kazuhiro ^a   Tanaka, Hiromu ^a   Shuto, Taichi ^a   Nishiguchi, Shuhei ^a   Kinoshita, Hiroaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis B virus; Hepatitis Bx RNA; Hepatitis C virus; Hepatocellular carcinoma; Occult infection

Indexed keywords

GENOMIC DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 4944228253     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-004-2818-1     Document Type: Article

References (51)

1. Kubo S, Nishiguchi S, Kuroki T, Hirohashi K, Tanaka H, Kinoshita H, et al. Poor association of GBV-C viremia with hepatocellular carcinoma. J Hepatol 1997;27:91-5.
2. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Kinoshita H, et al. High prevalence of infection with hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan. Hepatogastroenterology 1999;46:357-9.
3. Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994;35:828-32.
4. Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Kew M, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323:80-5.
5. Lai MY, Chen PJ, Yang PM, Sheu JC, Sung JL, Chen DS. Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology 1990;12:575-81.
6. Sheu JC, Huang GT, Shih LN, Lee WC, Chou HC, Yang PM, et al. Hepatitis C and B virus in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992;103:1322-7.
7. Kobayashi S, Saigoh K, Urashima T, Asano T, Isono K. Detection of hepatitis B virus x transcripts in human hepatocellular carcinoma tissues. J Surg Res 1997;73:97-100.
8. Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Brechot C, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993;17:20-9.
9. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995;21:313-21.
10. Edamoto Y, Tani M, Kurata T, Abe K. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues. Cancer 1996;77:1787-91.
11. Takeuchi M, Fujimoto J, Niwamoto H, Yamamoto Y, Okamoto E. Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen negative patients. Dig Dis Sci 1997;42:2264-9.
12. Urashima T, Saigo K, Kobayashi S, Imaseki H, Matsubara H, Isono K, et al. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues. J Hepatol 1997;26:771-8.
13. Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Kinoshita M, et al. The role of previous infection of hepatitis B virus in HBs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. J Exp Clin Cancer Res 1999;18:379-89.
14. Tamori A, Nishiguchi S, Kubo S, Koh N, Moriyama Y, Kuroki T, et al. Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus. Hepatology 1999;29:1429-34.
15. Shintani Y, Yotsuyanagi H, Moriya K, Fujie H, Tsutsumi T, Koike K, et al. The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C. Cancer 2000;88:2478-86.
16. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999;341:22-6.
17. Blum HE, Liang TJ, Galun E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991;14:56-63.
18. Kuhns M, McNamara A, Mason A, Campbell C, Perrillo R. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 1992;103:1649-56.
19. Fong TL, Di-Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 1993;18:1313-8.
20. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996;2:1104-8.
21. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998;27:1736-42.
22. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Mushahwar IK, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-9.
23. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Kim JP, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
24. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-7.
25. Tagger A, Donato F, Ribero ML, Chiesa R, Tomasoni V, Nardi G, et al. A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Hepatology 1997;26:1653-7.
26. Bréchot C, Jaffredo F, Lagorce D, Gerken G, Meyer-zum- Büschenfelde KM, Naoumov N, et al. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol 1998;29:173-83.
27. Lightfoot K, Skelton M, Kew MC, Yu MC, Kedda MA, Hodkinson J, et al. Does hepatitis GB virus-C infection cause hepatocellular carcinoma in black Africans? Hepatology 1997;26:740-2.
28. Yuan JM, Govindarajan S, Ross RK, Yu MC. Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non-Asians in Los Angeles County, California. Cancer 1999;86:936-43.
29. Pineau P, Meddeb M, Raselli R, Qin LX, Terris B, Dejean A, et al. Effect of TT virus infection on hepatocellular carcinoma development: results of a Euro-Asian survey. J Infect Dis 2000;181:1138-42.
30. Nishiguchi S, Enomoto M, Shiomi S, Tanaka M, Fukuda K, Kuroki T, et al. TT virus infection in patients with chronic liver disease of unknown etiology. J Med Virol 2000;62:392-8.
31. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990;211:277-87.
32. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Otani S, et al. Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-5.
33. Minamitani S, Nishiguchi S, Kuroki T, Otani S, Monna T. Detection by ligase chain reaction of precore mutant of hepatitis B virus. Hepatology 1997;25:216-22.
34. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Mayumi M, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 1998;10:1-16.
35. Takahashi K, Hoshino H, Ohta Y, Yoshida N, Mishiro S. Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers. Hepatol Res 1998;12:233-9.
36. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
37. Fijiyama A, Miyanohara A, Nozaki C, Yoneyama T, Ohtomo N, Matsubara K. Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res 1983;11:4601-10.
38. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis diagnosis, grading and staging. Hepatology 1994;19:1513-20.
39. Chiba T, Matsuzaki Y, Abei M, Shoda J, Tanaka N, Aikawa T, et al. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol 1996;91:1195-203.
40. Yu MC, Yuan JM, Ross RK, Govindarajan S. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California. Hepatology 1997;25:226-8.
41. Kubo S, Nishiguchi S, Tamori A, Hirohashi K, Kinoshita H, Kuroki T. Development of hepatocellular carcinoma in patients with HCV infection, with or without past HBV infection, and relationship to age at the time of transfusion. Vox Sang 1998;74:129.
42. Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Chiba T, et al. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut 1999;45:284-8.
43. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Kinoshita H, et al. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer 1999;86:793-8.
44. Adachi H, Kaneko S, Matsushita E, Inagaki Y, Unoura M, Kobayashi K. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 1992;16:1334-7.
45. Shirakata Y, Kawada M, Fujiki Y, Sano Y, Sano H, Oda M. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH 3T3 cells. Jpn J Cancer Res 1989;80:617-21.
46. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351:317-20.
47. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994;91:2230-4.
48. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Harris CC, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997;94:14707-12.
49. Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991;252:842-4.
50. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Brechot PP. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "Occult"? Hepatology 2001;34:194-203.
51. Mimi CY, Myron JT, Sugantha G, Brian EH. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.